← Leaderboards
Nicholas Cowan
New York University School Of Medicine
$7,165,268
Attributed
$7,165,268
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $921.2K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,165,268 · 5
By mechanism
R01$7,165,268 · 5
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular Chaperones”
- Scott J Hultgren · Washington University$24,111,975
- Judith Frydman · Stanford University$23,842,034
- Wah Chiu · Baylor College Of Medicine$22,055,847
- Randal J. Kaufman · Indiana University Indianapolis$21,677,694
- Richard I. Morimoto · Northwestern University$18,534,805
- William Tobey Wickner · Dartmouth College$17,981,123
Research focus
Molecular ChaperonesTubulinMicrotubulesCofactorChaperonin CctBaseCultured CellsProteinsCellsPathway InteractionsResearch StudyStructurePlayGenesMutationCytosolic ChaperoninProtein FoldingPolymerizationBinding (Molecular Function)PolypeptideTissue /Cell CultureEnvironmentMonitorComplex
Grant awards (22)
Tubulin Mutations in Neuronal Migration Disorders$477,292
R01 · FY2016 · GM · contact PI
Tubulin Mutations in Neuronal Migration Disorders$477,292
R01 · FY2015 · GM · contact PI
Tubulin Mutations in Neuronal Migration Disorders$460,586
R01 · FY2013 · GM · contact PI
Tubulin Mutations in Neuronal Migration Disorders$460,586
R01 · FY2013 · GM · contact PI
Tubulin Mutations in Neuronal Migration Disorders$482,929
R01 · FY2012 · GM · contact PI
Role of alpha-Tubulin Mutations in Lissencephaly$447,380
R01 · FY2010 · HD · contact PI
Role of alpha-Tubulin Mutations in Lissencephaly$378,858
R01 · FY2009 · HD · contact PI
Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer$322,050
R01 · FY2009 · CA · contact PI
Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer$321,654
R01 · FY2008 · CA · contact PI
Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer$94,826
R01 · FY2008 · CA · contact PI
Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer$315,113
R01 · FY2007 · CA · contact PI
Protein Folding in the Eukaryotic Cytosol$327,439
R01 · FY2005 · DK
Protein Folding in the Eukaryotic Cytosol$327,439
R01 · FY2004 · DK
Protein Folding in the Eukaryotic Cytosol$327,358
R01 · FY2003 · DK
Protein Folding in the Eukaryotic Cytosol$4,600
R01 · FY2003 · DK
Protein Folding in the Eukaryotic Cytosol$393,213
R01 · FY2002 · DK
PREFOLDING AND PROTEIN FOLDING$270,646
R01 · FY2002 · GM
PROTEIN FOLDING IN THE EUKARYOTIC CYTOSOL$334,349
R01 · FY2001 · DK
PREFOLDING AND PROTEIN FOLDING$264,881
R01 · FY2001 · GM
PROTEIN FOLDING IN THE EUKARYOTIC CYTOSOL$84,000
R01 · FY2001 · DK
PROTEIN FOLDING IN THE EUKARYOTIC CYTOSOL$328,492
R01 · FY2000 · DK
PREFOLDING AND PROTEIN FOLDING$264,285
R01 · FY2000 · GM